(NASDAQ: QURE) Uniqure Nv's forecast annual revenue growth rate of 190.47% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 56.38%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.68%.
Uniqure Nv's revenue in 2025 is $20,201,000.On average, 5 Wall Street analysts forecast QURE's revenue for 2025 to be $2,061,828,359, with the lowest QURE revenue forecast at $410,613,720, and the highest QURE revenue forecast at $6,131,831,552. On average, 5 Wall Street analysts forecast QURE's revenue for 2026 to be $4,740,124,784, with the lowest QURE revenue forecast at $930,724,432, and the highest QURE revenue forecast at $10,232,493,902.
In 2027, QURE is forecast to generate $46,793,539,531 in revenue, with the lowest revenue forecast at $46,793,539,531 and the highest revenue forecast at $46,793,539,531.